AGER and chronic kidney disease: This could indicate a synergistic effect for these two ligands of the receptor of advanced glycation end products (RAGE) which drives significant endothelial activation, and the authors suggest a potential role for triggering atherosclerosis, particularly in patients with diabetes mellitus and/or chronic kidney disease [197].